Legato Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,825
| Closed | -$578K | – | 561 |
|
|
2024
Q1 | $578K | Buy |
9,825
+5,760
| +142% | +$339K | 0.07% | 410 |
|
|
2023
Q4 | $243K | Sell |
4,065
-2,415
| -37% | -$145K | 0.03% | 511 |
|
|
2023
Q3 | $246K | Sell |
6,480
-2,382
| -27% | -$90.6K | 0.04% | 498 |
|
|
2023
Q2 | $807K | Buy |
8,862
+1,901
| +27% | +$173K | 0.11% | 307 |
|
|
2023
Q1 | $459K | Hold |
6,961
| – | – | 0.08% | 372 |
|
|
2022
Q4 | $360K | Buy |
+6,961
| New | +$360K | 0.07% | 397 |
|